SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-20-000030
Filing Date
2020-02-19
Accepted
2020-02-19 08:05:15
Documents
2
Period of Report
2020-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158211749728222.html 4  
1 FORM 4 wf-form4_158211749728222.xml 4 3874
2 POA - SOFIA poa-sofia.htm EX-24 3327
  Complete submission text file 0001447028-20-000030.txt   8758
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARBUTUS BIOPHARMA CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
Sofia Michael J. (Reporting) CIK: 0001635324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 20627451